T&L Co. Ltd (340570) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.049x

Based on the latest financial reports, T&L Co. Ltd (340570) has a cash flow conversion efficiency ratio of 0.049x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩9.68 Billion ≈ $6.56 Million USD) by net assets (₩199.09 Billion ≈ $134.92 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see T&L Co. Ltd stock valuation for the company's overall valuation and market capitalisation.

T&L Co. Ltd - Cash Flow Conversion Efficiency Trend (2018–2024)

This chart illustrates how T&L Co. Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

T&L Co. Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of T&L Co. Ltd ranked by their cash flow conversion efficiency. Explore 340570 cash to earnings ratio to measure how well operating cash flow supports reported net income.

Company Cash Flow Conversion Efficiency
Mycenax Biotech
TWO:4726
-0.031x
Alicanto Minerals Ltd
AU:AQI
-0.078x
Paxman AB
ST:PAX
-0.014x
Maple Gold Mines Ltd
V:MGM
-0.344x
i-SENS Inc
KQ:099190
-0.004x
Hope Education Group Co. Ltd
F:HE1
0.049x
Wanhwa Enterprise Co
TW:2701
0.006x
Seoul City Gas
KO:017390
-0.022x

Annual Cash Flow Conversion Efficiency for T&L Co. Ltd (2018–2024)

The table below shows the annual cash flow conversion efficiency of T&L Co. Ltd from 2018 to 2024. View today's stock price for T&L Co. Ltd for real-time trading data and today's change.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2024-12-31 ₩171.44 Billion
≈ $116.18 Million
₩46.57 Billion
≈ $31.56 Million
0.272x +7.98%
2023-12-31 ₩129.55 Billion
≈ $87.80 Million
₩32.59 Billion
≈ $22.09 Million
0.252x +73.19%
2022-12-31 ₩106.07 Billion
≈ $71.88 Million
₩15.41 Billion
≈ $10.44 Million
0.145x -31.15%
2021-12-31 ₩90.09 Billion
≈ $61.05 Million
₩19.01 Billion
≈ $12.88 Million
0.211x +62.45%
2020-12-31 ₩71.95 Billion
≈ $48.76 Million
₩9.34 Billion
≈ $6.33 Million
0.130x -44.91%
2019-12-31 ₩33.23 Billion
≈ $22.52 Million
₩7.83 Billion
≈ $5.31 Million
0.236x +0.50%
2018-12-31 ₩27.24 Billion
≈ $18.46 Million
₩6.39 Billion
≈ $4.33 Million
0.235x --

About T&L Co. Ltd

KQ:340570 Korea Medical Devices
Market Cap
$147.57 Million
₩217.76 Billion KRW
Market Cap Rank
#17813 Global
#748 in Korea
Share Price
₩27050.00
Change (1 day)
+0.19%
52-Week Range
₩27000.00 - ₩65600.00
All Time High
₩84000.00
About

T&L Co., Ltd. engages in the manufacture and sale of medical and polymer material products in South Korea. Its chemical products include water borne resins, hardeners, functional additives, and urethane foam; wound care products, including hydrocolloid, foam, hydrogel, silicone, alginate, and other products; and orthopedic products, such as cast, splint, and other products. T&L Co., Ltd. was foun… Read more